StockNews.com lowered shares of Sangamo Therapeutics (NASDAQ:SGMO – Free Report) from a hold rating to a sell rating in a report released on Tuesday. Other analysts have also recently issued reports about the company. Bank of America cut Sangamo Therapeutics from a neutral rating to an underperform rating and lowered their target price for the […]